Last update: July 16, 2017
Safe. Compatible.
Minimal risk for breastfeeding and infant.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Nifurtimox is also known as
Nifurtimox in other languages or writings:
Nifurtimox belongs to this group or family:
Write to us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Used for treatment of Leishmania infection and American Trypanosomiasis (T. cruzi: Chagas Disease, -see specific info) and African (Trypanosomiasis T. gambiensis: Sleeping Sickness).
It is excreted into breastmilk in small amounts (Garcia-Bournissen 2010) and there have not been observed problems in infants from treated mothers (Schmid 2012), so many experts consider it compatible with breastfeeding (Sankale 1991 Barennes 2010).
Nifurtimox has been very well tolerated when administered directly to infants and newborns (Schmid 2012)
See below the information of this related product: